LMNA, lamin A/C, 4000

N. diseases: 824; N. variants: 285
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease CLINVAR
Familial Partial Lipodystrophy, Type 2
0.800 Biomarker disease GENOMICS_ENGLAND
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease BEFREE Familial partial lipodystrophy, Dunnigan type (FPLD; Mendelian Inheritance in Man #151660), is an autosomal dominant disorder characterized by loss of s.c. fat from the extremities and trunk since puberty and predisposition to insulin resistance and its complications. 10843151 2000
Familial Partial Lipodystrophy, Type 2
0.800 GermlineCausalMutation disease ORPHANET Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. 10739751 2000
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. 10655060 2000
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. 10587585 2000
Familial Partial Lipodystrophy, Type 2
0.800 GermlineCausalMutation disease ORPHANET Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. 10587585 2000
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. 10739751 2000
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. 11792809 2001
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. 12196663 2002
Familial Partial Lipodystrophy, Type 2
0.800 Biomarker disease GENOMICS_ENGLAND Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. 11799477 2002
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. 12015247 2002
Familial Partial Lipodystrophy, Type 2
0.800 Biomarker disease CTD_human Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene. 14510863 2003
Familial Partial Lipodystrophy, Type 2
0.800 Biomarker disease CTD_human Lack of mutations in LMNA, its promoter region, and the cellular retinoic acid binding protein II (CRABP II) in HIV associated lipodystrophy. 12844477 2003
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. 12629077 2003
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. 15372542 2004
Familial Partial Lipodystrophy, Type 2
0.800 Biomarker disease CTD_human Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone. 16241930 2005
Familial Partial Lipodystrophy, Type 2
0.800 Biomarker disease BEFREE The Dunnigan syndrome [FPLD2 (familial partial lipodystrophy of the Dunnigan type)] is due to mutations in LMNA encoding the lamin A/C, belonging to the complex group of laminopathies that could comprise muscular and cardiac dystrophies, neuropathies and syndromes of premature aging. 16246048 2005
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease BEFREE The objective of the study was to carry out mutational analysis of LMNA in two sisters with a particularly severe FPLD2 phenotype. 16636128 2006
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660). 17250669 2007
Familial Partial Lipodystrophy, Type 2
0.800 CausalMutation disease CLINVAR New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. 17711925 2007
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease UNIPROT The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress. 19220582 2009
Familial Partial Lipodystrophy, Type 2
0.800 GeneticVariation disease BEFREE Type 2 familial partial lipodystrophy (FPLD2) is characterised by loss of fat in the limbs and buttocks and results from mutations in the LMNA gene. 18805829 2009
Familial Partial Lipodystrophy, Type 2
0.800 Biomarker disease CTD_human Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy. 19793595 2009
Familial Partial Lipodystrophy, Type 2
0.800 Biomarker disease GENOMICS_ENGLAND The genetics of dilated cardiomyopathy. 20186049 2010